# Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage

> **NCT02176837** · PHASE2 · TERMINATED · sponsor: **Hope Pharmaceuticals** · enrollment: 6 (actual)

## Conditions studied

- Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Sodium Nitrite

## Key facts

- **NCT ID:** NCT02176837
- **Lead sponsor:** Hope Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06
- **Primary completion:** 2017-01-15
- **Final completion:** 2017-01-15
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02176837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02176837, "Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02176837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*